A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes
Status:
Recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a study of select drug therapies in patients with salivary gland cancer. The study
has two phases: a molecular profiling phase (phase 1) and a treatment phase (phase 2).
Based on the Molecular profiling results in phase the participants will receive matched
treatment if a specific aberration is identified or will receive treatment with Selinexor if
unmatched and no druggable aberration is identified.